Promotes insulin release, can be used only for type 2 diabetes. This class of oral hypoglycemic has a disulfiram-like reaction when combined with alcohol. What class of hypoglycemic medication is this?

A. Amide local anesthetics (e.g., lidocaine, bupivacaine, ropivacaine) have a very low risk of allergic reactions. True allergies are rare and usually related to preservatives rather than the amide molecule itself.

B. Ester local anesthetics (e.g., procaine, chloroprocaine, tetracaine) pose a higher risk of allergic reactionsbecause they are metabolized to para-aminobenzoic acid (PABA), which is a known allergen. Patients may develop urticaria, rash, or, rarely, anaphylaxis.

C. Lidocaine is an amide anesthetic, and allergic reactions are extremely rare. Most reported reactions are side effects or sensitivity to preservativesrather than true allergy to the drug.

D. Chloroprocaine is an ester-type local anesthetic, which carries a higher risk of allergic reactionscompared with amide anesthetics. Allergies are uncommon but possible due to PABA metabolites.

E. Cocaine is an ester-type local anestheticand is more likely to cause allergic reactionscompared with amides. Additionally, cocaine has sympathomimetic effectsthat can complicate its use, including cardiovascular stimulation.

A. Methimazole can occasionally cause mild liver enzyme elevations, but severe hepatotoxicity is rare. Significant liver toxicity is more commonly associated with propylthiouracil (PTU)than methimazole. Therefore, while liver function should be monitored, it is not the most dangerous toxicity of methimazole.

B. Thyrotoxicosisis a state of excess thyroid hormone, often resulting from hyperthyroidism or over-replacement of thyroid hormone therapy. Methimazole is used to treat hyperthyroidism, so it does not induce thyrotoxicosis; this makes it an irrelevant option for methimazole toxicity.

C. PTU toxicity refers specifically to the adverse effects associated with propylthiouracil, including liver failure and vasculitis. While related pharmacologically, this is not directly a toxicity of methimazole, which has a different adverse effect profile.

D. The most serious and potentially life-threatening toxicity of methimazole is agranulocytosis, which is a severe reduction in neutrophilsand other white blood cells. This can lead to rapidly developing infections, even from normally harmless bacteria. Patients on methimazole should be educated to report fever, sore throat, or signs of infection immediately, as early recognition and prompt discontinuation of the drug are critical. Routine blood counts may be monitored during therapy, especially during the first few months of treatment. Although rare, agranulocytosis requires urgent medical attention and sometimes hospitalization.